Characterization of Amorphous Celecoxib Mixed with Plasticizing (TPGS) and Anti-plasticizing (PVP) Ingredients Using Hot Melt Extrusion
- 7 Downloads
Hot melt extrusion (HME) has demonstrated to be an adequate compounding method for poorly soluble pharmaceutical drugs, as it increases its solubility by fixing its amorphous solid-state using polymers (plasticizing) and other ingredients (non-plasticizing). However, its amorphous state of the drug and the stability of the amorphous state will greatly depend on its interactions with these (plasticizing or not).
In this study, we aimed at characterizing the impact of the combination of plasticizing (TPGS) and anti-plasticizing (PVP) ingredients in amorphous celecoxib prepared using HME in terms of chemical interactions between the components (FTIR, Raman, and NMR), viscoelasticity (loss and storage modulus), and required energy for flow (activation energy). Different celecoxib/PVP/TPGS ratios were studied to understand the synergistic effect of PVP and TPGS in inhibiting the crystallization of celecoxib when preparing amorphous dispersions using HME. We aimed at linking the viscoelastic properties of the melt with the resulting amorphous state described by the chemical interactions upon extrusion.
The amorphous state of celecoxib was evidenced by strengthening of H-bonding between celecoxib and PVP, lack of characteristic crystalline peaks of celecoxib, and deshielding of aromatic protons. The melt was also characterized in terms of viscoelastic temperature dependent behavior (liquid G"; elastic G'), where increasing amounts of TPGS and PVP showed opposites effects; TPGS reduced the viscoelastic response whereas PVP increased it. Calculated melt activation energies (Ea) from the temperature dependent viscosity revealed a threshold of TPGS concentration where samples with 1% w/w of TPGS showed higher flow activation energies (higher Ea) independent of the drug/polymer ratios, compared with samples with higher amounts of TPGS.
Low drug content combined with anti-plasticizing (PVP) amounts and relatively low plasticizing (TPGS) amounts yields an amorphous dispersion that is characterized with strong H-bonding due to efficient mixing using HME.
KeywordsHot melt extrusion Amorphous drugs Rheology Activation energy
Infrastructure support was provided in part by the National Institute on Minority Health and Health Disparities RCMI Grant: 8G12MD007600. The authors thank the University of Puerto Rico (UPR) Molecular Sciences Research Building (MSRB) for providing the use of the FTIR and Raman instruments and Ramonita Ayala for assistance with these.
- 8.Chokshi RJ, Sandhu HK, Iyer RM, Shah NH, Malick AW, Zia H. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion process as a means to manufacture solid dispersion/solution. J Pharm Sci. 2005;94:2463–74.CrossRefGoogle Scholar
- 17.Messaâdi A, Dhouibi N, Hamda H, Belgacem FBM, Adbelkader YH, Ouerfelli N, and Hamzaoui AH. A new equation relating the viscosity Arrhenius temperature and the activation energy for some Newtonian classical solvents. J Chem. 2015;7–10.Google Scholar
- 18.Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. Role of molecular interaction in stability of celecoxib - PVP amorphous systems. Mol Pharm. 2005;3:1700–5.Google Scholar
- 20.Gupta SS, Meena A, Parikh T, and Serajuddin ATM. Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion - I : Polyvinylpyrrolidone and related polymers. 2014;5:32–45.Google Scholar
- 21.Kumar S, Radhakrishnan VK, Davis VA, Parsons DL, Babu J. Amorphous-state characterization of efavirenz-polymer hot-melt extrusion systems for dissolution enhancement. Int J Drug Dev Res. 2011;101:3456–64.Google Scholar